Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 7—July 2011


Visceral Larva Migrans in Immigrants from Latin America

Maria-Carmen Turrientes, Ana Pérez de Ayala, Francesca Norman, Miriam Navarro, José-Antonio Pérez-Molina, Mercedes Rodriquez-Ferrer, Teresa Gárate, and Rogelio López-VélezComments to Author 
Author affiliations: Author affiliations: Ramón y Cajal Hospital, Madrid, Spain (M.-C. Turrientes, A. Pérez de Ayala, F. Norman, M. Navarro, J.-A. Pérez-Molina, R. López-Vélez); Institute de Salud Carlos III, Madrid (T. Gárate, M. Rodriquez-Ferrer)

Main Article


Descriptions of 4 cases of visceral larva migrans in immigrants from Latin America, Spain, April 1989–June 2008*

Case no.
Age, y/sex
Clinical signs and symptoms
Chest radiograph results
Eosinophil count,
absolute/mm3 (%)
6-mo follow-up
Eosinophil count/mm3
Decrease in antibody titers
1 28/M Bolivia Asthma-like syndrome† Slight right parahiliar infiltrate 700 (17.0) 500 Yes None
2 29/F Dominican Republic Dry cough, dyspnea, chest pain, eosinophilic pneumonia Bilateral alveolar infiltrates 1,400 (10.5) 600 Yes None
3 5/F Ecuador Asthma-like syndrome, abdominal pain No findings 1,050 (15.0) 700 Yes None
4 40/F Colombia Abdominal pain Not done 1,500 (14.8) 400 Yes Clinical improvement

*All patients were treated with albendazole (10–15 mg/kg/d in 2 doses orally for 5 days).
†Wheezing and dry cough.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO